Detalles de la búsqueda
1.
Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study.
Ann Oncol
; 29(6): 1409-1416, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29668860
2.
Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancer.
ESMO Open
; 7(1): 100333, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35042152
3.
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudes.
Clin Transl Oncol
; 22(6): 844-851, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31392645
4.
Induction cisplatin-gemcitabine-paclitaxel plus concurrent radiotherapy and gemcitabine in the multimodality treatment of unresectable stage IIIB non-small cell lung cancer.
Lung Cancer
; 54(3): 331-8, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17011065
5.
Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC.
Br J Radiol
; 88(1048): 20140728, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25645106
6.
The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: a phase III randomized FONICAP trial. Italian Lung Cancer Task Force.
Tumori
; 85(3): 177-82, 1999.
Artículo
en Inglés
| MEDLINE | ID: mdl-10426128
7.
Locally advanced non-small cell lung cancer: role of induction chemotherapy in resectable N2 disease.
Ann Oncol
; 17 Suppl 2: ii28-31, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16608976
8.
Spirometric prediction equations for male Italians 7-18 years of age.
Eur J Epidemiol
; 12(3): 263-77, 1996 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-8884194
9.
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
Br J Cancer
; 77(12): 2367-70, 1998 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-9649160
10.
[Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung]. / Utilità dell'antigene carcinoembrionario (CEA), dell'antigene polipeptidico tessutale (TPA), dell'enolasi (NSE) e della timidina-kinasi (TK) nel monitoraggio e nella prognosi del carcinoma polmonare primitivo.
J Nucl Med Allied Sci
; 34(4 Suppl): 135-40, 1990.
Artículo
en Italiano
| MEDLINE | ID: mdl-1965445
Resultados
1 -
10
de 10
1
Próxima >
>>